Leukine Is Divestment Candidate In Amgen/Immunex Deal
Executive Summary
Immunex' Leukine is available for licensing as part of Amgen's acquisition of the biotech company
You may also be interested in...
Kineret Gets Rheumatologist Promotions From 35-Rep NPS Force
NPS will promote Amgen's rheumatoid arthritis agent Kineret to rheumatologists with a 35 member specialty sales force
Kineret Gets Rheumatologist Promotions From 35-Rep NPS Force
NPS will promote Amgen's rheumatoid arthritis agent Kineret to rheumatologists with a 35 member specialty sales force
FTC Allows Genzyme/Novazyme Merger, Finds No Product Development Delay
The merger of Genzyme and Novazyme does not merit antitrust activity because it does not result in the delay of Pompe therapy development, the Federal Trade Commission said Jan. 13